Bridgeway Capital Management, LLC Evelo Biosciences, Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.86 - $41.8 $195,858 - $4.4 Million	105,300 New	105,300 $220,000
Q3 2020 Nov 16, 2020	SELL	$3.81 - $5.73 $260,985 - $392,505	-68,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.53 - $6.12 $229,450 - $397,800	-65,000 Reduced 48.69%	68,500 $336,000
Q4 2019 Feb 14, 2020	BUY	$3.81 - $7.45 $508,635 - $994,575	133,500 New	133,500 $542,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.